| Title |
Published on |
Year |
| Neuroendocrine tumors and diabetes mellitus: which treatment and which effect |
ENDOCRINE |
2025 |
| “Cold” Somatostatin Analogs in Neuroendocrine Neoplasms:
Decoding Mechanisms, Overcoming Resistance, and Shaping the
Future of Therapy |
CELLS |
2025 |
| Impact of dyslipidemia and lipid-lowering therapy with statins in patients with neuroendocrine tumors |
JOURNAL OF NEUROENDOCRINOLOGY |
2025 |
| Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor Origins |
NEUROENDOCRINOLOGY |
2025 |
| Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas. results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial |
THE LANCET |
2024 |
| Short fasting test as a reliable and effective tool to diagnose insulinoma |
ENDOCRINE |
2024 |
| Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group |
CANCER TREATMENT REVIEWS |
2024 |
| Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force |
JOURNAL OF NEUROENDOCRINOLOGY |
2024 |
| Rachel score: a nomogram model for predicting the prognosis of lung neuroendocrine tumors |
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION |
2024 |
| Radioligand Therapy in Patients with Lung Neuroendocrine Tumors: A Systematic Review on Efficacy and Safety |
SEMINARS IN NUCLEAR MEDICINE |
2024 |
| Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view |
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION |
2024 |
| Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons |
ENDOCRINE |
2024 |
| Sexual and reproductive health: level of knowledge and source of information in adolescence |
JOURNAL OF SEXUAL MEDICINE |
2024 |
| Seminological, hormonal and ultrasonographic features of male factor infertility due to genetic causes: results from a large monocentric retrospective study |
JOURNAL OF CLINICAL MEDICINE |
2024 |
| Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM) |
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION |
2024 |
| Comparative Targeted Genome Profiling between Solid and Liquid Biopsies in Gastroenteropancreatic Neuroendocrine Neoplasms: A Proof-of-Concept Pilot Study |
NEUROENDOCRINOLOGY |
2024 |
| Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)-An ENETS MEN1 task force questionnaire study |
JOURNAL OF NEUROENDOCRINOLOGY |
2024 |
| Nutritional status and gastroenteropancreatic neuroendocrine neoplasms: lights and shadows with a clinical guide from the NIKE Group |
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS |
2024 |
| Exploring carcinoid syndrome in neuroendocrine tumors: insights from a multidisciplinary narrative review |
CANCERS |
2024 |
| Neuroendocrine neoplasms of the breast: a multicenter retrospective Italian study |
MINERVA ENDOCRINOLOGY |
2024 |
